0001493152-24-001138.txt : 20240104
0001493152-24-001138.hdr.sgml : 20240104
20240104195527
ACCESSION NUMBER: 0001493152-24-001138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231221
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zulueta Alfonso G
CENTRAL INDEX KEY: 0001596336
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40789
FILM NUMBER: 24514105
MAIL ADDRESS:
STREET 1: 4925 INDIANA AVE
CITY: LISLE
STATE: IL
ZIP: 60532
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calidi Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001855485
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 862967193
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4475 EXECUTIVE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-794-9600
MAIL ADDRESS:
STREET 1: 4475 EXECUTIVE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: First Light Acquisition Group, Inc.
DATE OF NAME CHANGE: 20210406
4
1
ownership.xml
X0508
4
2023-12-21
1
0001855485
Calidi Biotherapeutics, Inc.
CLDI
0001596336
Zulueta Alfonso G
C/O CALIDI BIOTHERAPEUTICS, INC.
4475 EXECUTIVE DRIVE, SUITE 200
SAN DIEGO,
CA
92121
1
0
0
0
0
Common Stock
2023-12-21
4
A
0
5644
1.80
A
133301
D
Represents a grant of restricted stock units ("RSUs") subject to the conditions of the Restricted Stock Unit Award Agreement pursuant to the Issuer's 2023 Plan. Each RSU represents a right to receive one share of the Company's common stock upon vesting. The number of RSUs to be issued will equal to the amount due to the director for Board fees divided by the closing price for a share of the Issuer's common stock. The RSUs were granted in a transaction exempt under Rule 16b-3 to the Reporting Person. The shares of common stock underlying the RSUs immediately vested on the grant date. As previously reported, Mr. Alfonso resigned as a director on November 29, 2023.
/s/ Wendy Pizarro, Attorney-in-fact
2024-01-04